Avanos Medical, Inc.2025财年第二财季实现净利润-76.80百万美元，同比减少1886.05%

市场透视2025-08-11

8月11日，Avanos Medical, Inc.（AVNS.US）公布财报，公告显示公司2025财年第二财季净利润为-76.80百万美元，同比减少1886.05%；其中营业收入为1.75亿美元，同比增加1.74%，每股基本收益为-1.66美元。从资产负债表来看，Avanos Medical, Inc.（AVNS.US）总负债2.63亿美元，其中短期债务19.80百万美元，资产负债比为3.96，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558268129?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-11 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558268129","market":"us","top_or_hot":-1,"title":"Avanos Medical, Inc.2025财年第二财季实现净利润-76.80百万美元，同比减少1886.05%","media":"市场透视","content":"<div>\n<p>8月11日，Avanos Medical, Inc.（AVNS.US）公布财报，公告显示公司2025财年第二财季净利润为-76.80百万美元，同比减少1886.05%；其中营业收入为1.75亿美元，同比增加1.74%，每股基本收益为-1.66美元。从资产负债表来看，Avanos Medical, Inc.（AVNS.US）总负债2.63亿美元，其中短期债务19.80百万美元，资产负债比为3.96，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000107a6de06bf&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avanos Medical, Inc.2025财年第二财季实现净利润-76.80百万美元，同比减少1886.05%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvanos Medical, Inc.2025财年第二财季实现净利润-76.80百万美元，同比减少1886.05%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-11 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000107a6de06bf&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月11日，Avanos Medical, Inc.（AVNS.US）公布财报，公告显示公司2025财年第二财季净利润为-76.80百万美元，同比减少1886.05%；其中营业收入为1.75亿美元，同比增加1.74%，每股基本收益为-1.66美元。从资产负债表来看，Avanos Medical, Inc.（AVNS.US）总负债2.63亿美元，其中短期债务19.80百万美元，资产负债比为3.96，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000107a6de06bf&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVNS","symbol_name":"AVANOS MEDICAL","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000107a6de06bf&s=b","article_id":"2558268129","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000107a6de06bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558268129","pubTimestamp":1754841641,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月11日，Avanos Medical, Inc.公布财报，公告显示公司2025财年第二财季净利润为-76.80百万美元，同比减少1886.05%；其中营业收入为1.75亿美元，同比增加1.74%，每股基本收益为-1.66美元。从资产负债表来看，Avanos Medical, Inc.总负债2.63亿美元，其中短期债务19.80百万美元，资产负债比为3.96，流动比率为2.64。机构评级：截至2025年8月11日，当前有1家机构对Avanos Medical, Inc.目标价做出预测，其中目标均价为14.00美元，其中最低目标价为14.00美元，最高目标价为14.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"AVNS":"AVANOS MEDICAL"},"translate_title":"Avanos Medical, Inc. achieved net profit of-76.80 million US dollars in the second fiscal quarter of fiscal year 2025, a year-on-year decrease of 1886.05%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVNS":0.9},"content_text":"8月11日，Avanos Medical, Inc.（AVNS.US）公布财报，公告显示公司2025财年第二财季净利润为-76.80百万美元，同比减少1886.05%；其中营业收入为1.75亿美元，同比增加1.74%，每股基本收益为-1.66美元。从资产负债表来看，Avanos Medical, Inc.（AVNS.US）总负债2.63亿美元，其中短期债务19.80百万美元，资产负债比为3.96，流动比率为2.64。机构评级：截至2025年8月11日，当前有1家机构对Avanos Medical, Inc.目标价做出预测，其中目标均价为14.00美元，其中最低目标价为14.00美元，最高目标价为14.00美元。公司简介：爱诺生医疗器械有限公司是一家总部位于美国的公司，全球范围内开发和销售医疗器械及相关服务。其运营和可报告的业务部门向医疗服务提供者和患者提供医疗器械产品。公司目前进行了两项特许经营权的整合：将慢性病护理和疼痛管理特许经营权合并为一个专注于消化健康和疼痛管理及康复产品类别的单一商业组织，该组织的收入来源于其慢性病护理特许经营权并在北美地区的运营。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558268129","isCrawlerRequest":true}